People Biography

Dr. Maryam Saifaldeen is a Senior Research Associate at the Translational Oncology Research Center at QBRI. With her academic journey supported by the Qatar Research Leadership Program (QRLP), Maryam Saifaldeen earned a BSc in Biological Sciences from the University of Southampton, an MRes in Molecular and Cellular Biosciences from Imperial College of London, and a PhD in Genomics and Precision Medicine from Hamad Bin Khalifa University. This multidisciplinary academic training provided a strong foundation in molecular biology, functional genomics, and biomedical research.

Her doctoral research focused on CRISPR/Cas9-based gene editing, leading to the identification of the E3 ubiquitin ligase beta-TrCP1 as a novel regulator of cellular lipid metabolism. Her PhD work contributed to two first-author publications and one co-authored review article.

Dr. Maryam Saifaldeen’s growing research interests lie in understanding how metabolic rewiring of tumor and immune cells influences therapy response, particularly in triple-negative breast cancer. She is committed to contributing to Qatar’s national cancer research efforts by promoting translational science, interdisciplinary collaboration, and innovation-driven discovery.